TKNO
Alpha Teknova IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$175.31M
P/E Ratio
—
EPS
$-0.32
Beta
0.33
52W High
$7.48
52W Low
$1.91
50-Day MA
$2.70
200-Day MA
$4.00
Dividend Yield
—
Profit Margin
-42.60%
Forward P/E
—
PEG Ratio
—
About Alpha Teknova Inc
Alpha Teknova Inc (TKNO) is a prominent player in the synthetic biology sector, providing essential biological reagents and supplements that support life sciences research and biomanufacturing. The company meets critical demands in areas such as vaccine development, cell and gene therapy, and diagnostic testing, driven by a dedication to quality and outstanding customer service. Leveraging its strong biotechnology foundation and an unwavering focus on innovation, Alpha Teknova is strategically positioned to seize growth opportunities in the rapidly evolving life sciences market, thereby enhancing value for its investors.
Fundamentals
| Revenue (TTM) | $40.52M |
| Gross Profit (TTM) | $13.44M |
| EBITDA | $-10.13M |
| Operating Margin | -41.20% |
| Return on Equity | -22.80% |
| Return on Assets | -9.26% |
| Revenue/Share (TTM) | $0.76 |
| Book Value | $1.28 |
| Price-to-Book | 2.55 |
| Price-to-Sales (TTM) | 4.33 |
| EV/Revenue | 4.497 |
| EV/EBITDA | -6.23 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 7.80% |
| Shares Outstanding | $53.61M |
| Float | $10.33M |
| % Insiders | 9.32% |
| % Institutions | 83.41% |
Historical Volatility
HV 10-Day
74.63%
HV 20-Day
80.72%
HV 30-Day
76.75%
HV 60-Day
84.36%
HV Rank
62.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($9.00 target)
4
Buy2
HoldData last updated: 4/29/2026